Akari Therapeutics Plc (AKTX)
11.30
+0.42
(+3.86%)
USD |
NASDAQ |
Sep 11, 16:00
11.92
+0.62
(+5.49%)
After-Hours: 20:00
Akari Therapeutics Market Cap : 19.78M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 19.78M |
| September 10, 2026 | 19.04M |
| September 09, 2026 | 18.50M |
| September 08, 2026 | 19.18M |
| September 04, 2026 | 20.08M |
| September 03, 2026 | 18.97M |
| September 02, 2026 | 17.77M |
| September 01, 2026 | 18.15M |
| August 31, 2026 | 18.26M |
| August 28, 2026 | 18.73M |
| August 27, 2026 | 15.77M |
| August 26, 2026 | 15.93M |
| August 25, 2026 | 13.78M |
| August 24, 2026 | 13.08M |
| August 21, 2026 | 13.74M |
| August 20, 2026 | 13.64M |
| August 19, 2026 | 13.83M |
| August 18, 2026 | 13.83M |
| August 17, 2026 | 13.16M |
| August 14, 2026 | 13.20M |
| August 13, 2026 | 12.25M |
| August 12, 2026 | 12.57M |
| August 11, 2026 | 13.53M |
| August 10, 2026 | 8.619M |
| August 07, 2026 | 8.012M |
| Date | Value |
|---|---|
| August 06, 2026 | 9.248M |
| August 05, 2026 | 8.584M |
| August 04, 2026 | 8.916M |
| August 03, 2026 | 8.424M |
| July 31, 2026 | 8.997M |
| July 30, 2026 | 9.157M |
| July 29, 2026 | 9.443M |
| July 28, 2026 | 9.649M |
| July 27, 2026 | 9.683M |
| July 24, 2026 | 9.958M |
| July 23, 2026 | 10.64M |
| July 22, 2026 | 11.23M |
| July 21, 2026 | 10.64M |
| July 20, 2026 | 12.20M |
| July 17, 2026 | 12.60M |
| July 16, 2026 | 13.16M |
| July 15, 2026 | 13.82M |
| July 14, 2026 | 15.36M |
| July 13, 2026 | 15.34M |
| July 10, 2026 | 15.89M |
| July 09, 2026 | 15.06M |
| July 08, 2026 | 16.26M |
| July 07, 2026 | 17.72M |
| July 06, 2026 | 12.48M |
| July 02, 2026 | 11.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 701.32M |
| Cellectis SA | 312.16M |
| argenx SE | 60.92B |
| Autolus Therapeutics Plc | 500.39M |
| Evaxion AS | 26.10M |
Market Cap Related Metrics
| PEG Ratio | -0.0009 |
| Price to Book Value | 1.064 |
| Price | 11.30 |
| Earnings Yield | -175.0% |
| PEGY Ratio | -0.0009 |